Brodalumab

LUMICEF Subcutaneous Injection 210mg Syringe

注射液劑TaiwanAuthorisedAuthorised 25 Jun 2018

In other countries

The same active substances on other registers, the same brand first.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Brodalumab

LUMICEF Subcutaneous Injection 210mg Syringe

注射液劑TaiwanAuthorisedAuthorised 25 Jun 2018

Ask Osler about it

In other countries

The same active substances on other registers, the same brand first.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

SiliqUnited States · 210MG/1.5ML · injectable · Valeant Luxembourg

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Taiwan Food and Drug Administration

TFDA, dataset 9122, Government Open Data Licence 1.0; source update and retrieval dates

Licence: Taiwan Government Open Data Licence 1.0 · Added 7 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Brodalumab
Dosage form: 注射液劑
Register: Taiwan (TFDA)
Status: Authorised
Authorised: 25 Jun 2018
Registration: 衛部菌疫輸字第001076號
Marketing authorisation holder: 台灣大昌華嘉股份有限公司
Procedure: 菌　疫